Ethan Bier
7Patents
1h-index
11Co-inventors
48Inventor score
Filing activity: Dec 16, 1998 → Aug 23, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6806358B1 | Peptide inhibitor of TGF-&bgr; growth factors | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7193126B2 | Method for generating overexpression of alleles in genes of unknown function | Human Necessities | 1 | Expired |
| US7692059B2 | Method for generating overexpression of alleles in genes of unknown function | Human Necessities | 0 | Active |
| US11083708B2 | Pharmacological restoration of epithelial or endothelial barrier integrity by agents blocking EPAC/RAP1 signaling | Human Necessities | 0 | Active |
| US11091780B2 | Methods for autocatalytic genome editing and neutralizing autocatalytic genome editing and compositions thereof | Chemistry; Metallurgy | 0 | Active |
| US9095579B2 | Protection and treatment against influenza infection | Human Necessities | 0 | Active |
| US7402566B2 | Peptide inhibitor of TGF-β growth factors | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.